US2025333803A1PendingUtilityA1
Novel compositions, methods and kits for urinary tract microorganism detection
Est. expiryNov 13, 2037(~11.3 yrs left)· nominal 20-yr term from priority
Inventors:Kelly LiIoanna PaganiJisheng LiSunali PatelKamini VarmaJorge FonsecaNitin PuriEvan Diamond
C12Q 2600/16C12Q 1/686C12Q 1/6837C12Q 1/6895C12Q 1/689
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Various methods are disclosed for amplifying nucleic acid sequences in a nucleic acid sample. The methods involve forming at least five amplification reaction mixes each including an aliquot from a sample source that includes nucleic acid sequences, using at least five different assays each including a pair of amplification primers, the assays selected from the group of assays in Table 1 and/or targeting the sequences specified in Table 1.
Claims
exact text as granted — not AI-modified1 . A method for amplifying at least one target nucleic acid in a biological sample, the method comprising:
forming one or more amplification reaction mixes, each amplification reaction mix comprising: a biological sample and a nucleic acid primer with a target hybridization region; and subjecting each amplification reaction mix to conditions suitable for the target hybridization region to hybridize to at least a portion of a region of SEQ ID NOs: 1 to 19.
2 . The method of claim 1 further comprising the step of applying each amplification reaction mix to a reaction vessel.
3 . The method of claim 2 , wherein the reaction vessel is a plate with a plurality of wells.
4 . The method of claim 2 , wherein the reaction vessel is an array.
5 . The method of claim 2 , wherein the reaction vessel is an open array plate.
6 . The method of claim 2 , wherein the reaction vessel is a chip microarray.
7 - 54 . (canceled)
55 . A composition for detecting the presence of of at least one target nucleic acid in a biological sample, the composition comprising:
one or more nucleic acid primers, wherein each of said one or more nucleic acid primers comprises a target hybridization region that is configured to specifically hybridize to at least a portion of a region of SEQ ID NOs: 1 to 19.
56 . The composition of claim 55 , further comprising a control nucleic acid molecule comprising a plurality of different nucleic acid target sequences, said plurality of target nucleic acid sequences being specific to at least five genes in Table 1.
57 . The composition of claim 55 , wherein the composition is a panel or a collection of assays.
58 . The composition of claim 57 , wherein the panel or collection of assays comprise a panel or collection of TaqMan Assays.
59 . The composition of claim 55 , wherein the at least one target nucleic acid is a biomarker for a microbe associated with a urinary tract infection.
60 . The composition of claim 55 , wherein the composition comprises a solid support.
61 . The composition of claim 60 , wherein two or more nucleic acid primers are separated by location on the solid support.
62 - 287 . (canceled)Join the waitlist — get patent alerts
Track US2025333803A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.